As the comparatively higher allele frequency and risk association of the LRRK2 p.A419V in European individuals was unique to the GP2 EUR cohort - unlike the other EUR cohorts from AMP-PD, UKB, and AOU - carriers in this group were examined further. This evidence concerns the gene LRRK2 and Parkinson disease.